HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Appendix Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stern, S. E. Articles by Stern, M. P. Search for Related Content PubMed PubMed Citation Articles by Stern, S. E. Articles by Stern, M. P. Social Bookmarking                What's this?

Identification of Individuals With Insulin Resistance Using Routine Clinical Measurements

¹ School of Finance and Applied Statistics, Australian National University, Canberra, Australia
² Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas
³ CNR Institute of Clinical Physiology, Pisa, Italy
⁴ Division of Diabetes, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas
⁵ Clinical Diabetes and Nutrition Section, National Institute of Diabetes and Digestive and Kidney Diseases/National Institutes of Health, Phoenix, Arizona

Insulin resistance is a treatable precursor of diabetes and potentially of cardiovascular disease as well. To identify insulin-resistant patients, we developed decision rules from measurements of obesity, fasting glucose, insulin, lipids, and blood pressure and family history in 2,321 (2,138 nondiabetic) individuals studied with the euglycemic insulin clamp technique at 17 European sites; San Antonio, Texas; and the Pima Indian reservation. The distribution of whole-body glucose disposal appeared to be bimodal, with an optimal insulin resistance cutoff of <28 µmol/min · kg lean body mass. Using recursive partitioning, we developed three types of classification tree models: the first, based on clinical measurements and all available laboratory determinations, had an area under the receiver operator characteristic curve (aROC) of 90.0% and generated a simple decision rule: diagnose insulin resistance if any of the following conditions are met: BMI >28.9 kg/m², homeostasis model assessment of insulin resistance (HOMA-IR) >4.65, or BMI >27.5 kg/m² and HOMA-IR >3.60. The fasting serum insulin concentrations corresponding to these HOMA-IR cut points were 20.7 and 16.3 µU/ml, respectively. This rule had a sensitivity and specificity of 84.9 and 78.7%, respectively. The second model, which included clinical measurements but no laboratory determinations, had an aROC of 85.0% and generated a decision rule that had a sensitivity and specificity of 78.7 and 79.6%, respectively. The third model, which included clinical measurements and lipid measurements but not insulin (and thus excluded HOMA-IR as well), had a similar aROC (85.1%), sensitivity (81.3%), and specificity (76.3%). Thus, insulin-resistant individuals can be identified using simple decision rules that can be tailored to specific needs.

Abbreviations: aROC, area under the receiver operator characteristic curve; EGIR, European Group for the Study of Insulin Resistance; HOMA-IR, homeostasis model assessment of insulin resistance

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Beysen, E. J. Murphy, T. McLaughlin, T. Riiff, C. Lamendola, H. C. Turner, M. Awada, S. M. Turner, G. Reaven, and M. K. Hellerstein Whole-Body Glycolysis Measured by the Deuterated-Glucose Disposal Test Correlates Highly With Insulin Resistance In Vivo Diabetes Care, May 1, 2007; 30(5): 1143 - 1149. [Abstract] [Full Text] [PDF]

				E. Ferrannini Metabolic Syndrome: A Solution in Search of a Problem J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 396 - 398. [Full Text] [PDF]

				C. Li, E. S Ford, L. C McGuire, and A. H Mokdad Association of metabolic syndrome and insulin resistance with congestive heart failure: findings from the Third National Health and Nutrition Examination Survey J. Epidemiol. Community Health, January 1, 2007; 61(1): 67 - 73. [Abstract] [Full Text] [PDF]

				C. Li, E. S. Ford, L. C. McGuire, A. H. Mokdad, R. R. Little, and G. M. Reaven Trends in hyperinsulinemia among nondiabetic adults in the u.s. Diabetes Care, November 1, 2006; 29(11): 2396 - 2402. [Abstract] [Full Text] [PDF]

				M. J. LaMonte, S. N. Blair, and T. S. Church Physical activity and diabetes prevention J Appl Physiol, September 1, 2005; 99(3): 1205 - 1213. [Abstract] [Full Text] [PDF]

				R. Kahn, J. Buse, E. Ferrannini, and M. Stern The Metabolic Syndrome: Time for a Critical Appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes Diabetes Care, September 1, 2005; 28(9): 2289 - 2304. [Abstract] [Full Text] [PDF]

				W. Rathmann, B. Haastert, G. Giani, R. Holle, W. Koenig, C. Herder, and H. Lowel Critical Evaluation of Models to Identify Individuals With Insulin Resistance Diabetes Care, July 1, 2005; 28(7): 1833 - 1833. [Full Text] [PDF]